UgenTec, headquartered in Hasselt, Belgium, is carving a niche in the Biotechnology and Healthcare industries. Founded in 2014, the company has developed a strong reputation as a leading molecular laboratory software provider.
Their flagship product, the FastFinder platform, is a Software as a Service (SaaS) that utilizes AI to enhance and automate workflows in molecular diagnostics. With modules like Analysis, Genotyper, and Workflow, it is designed to meet the needs of a diverse range of applications, from Clinical Molecular Diagnostics to Crop Science.
The company’s global influence is reflected in its presence across over 100 molecular labs and ties with top molecular diagnostics vendors. In 2018, UgenTec secured a €7.50M Series A investment from notable investors, including Limburgse Reconversie Maatschappij and imec. The investment underscores confidence in UgenTec's potential to further innovate and expand its reach in a growing market.